aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Nov 14, 2017 · 10-Q · 45 days after period end · 0001564590-17-023776
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$11.19M | -$13.82M | -$11.33M | -$6.63M |
| EPS Diluted | -$0.43 | -$0.58 | -$0.48 | -$8.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end
